Element Solutions
ESI NYSE Specialty Chemicals Financials FY2016βFY2025
Element Solutions' revenue rose 3.8% to $2.6 billion in fiscal 2025. Its operating margin was 13.4%, down from 14.0% a year earlier. Free cash flow was $228 million, down 22.5%. It paid out $103 million in dividends and buybacks, 45% of free cash flow.
What Element Solutions does
No business description yet.
- Legal name
- Element Solutions Inc
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001590714-26-000018
0001590714
Revenue and margins
Element Solutions had $2.6B of revenue in fiscal 2025, up 3.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $228M in fiscal 2025, 8.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Element Solutions returned $103M to shareholders in fiscal 2025, 45% of free cash flow. The diluted share count fell 0.1%.
Value Element Solutions yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.0B and divides by 242.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 39.1x Β· peers 20.5x Β· sector 20.1x.
Balance sheet
Cash, debt and the ratios that show how comfortably Element Solutions can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $330M | $266M | $289M | $359M | $627M |
| Debt incl. finance leases | $1.9B | $1.9B | $2.0B | $1.8B | $1.6B |
| Net debt / EBITDA | 3.5x | 3.4x | 4.9x | 3.0x | 2.1x |
| Debt / equity | 0.8x | 0.8x | 0.8x | 0.8x | 0.6x |
| Current ratio | 2.9x | 3.5x | 3.2x | 3.3x | 3.7x |
| Quick ratio | 2.3x | 2.6x | 2.4x | 2.7x | 3.0x |
| Total assets | $5.1B | $4.9B | $5.0B | $4.9B | $5.1B |
| Total liabilities | $2.6B | $2.6B | $2.6B | $2.5B | $2.4B |
| Shareholders' equity | $2.5B | $2.3B | $2.3B | $2.4B | $2.7B |
| Net debt (β = net cash) | $1.6B | $1.6B | $1.7B | $1.5B | $1.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$25.7M
5 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Benjamin GliklichCEO, Director | Sold | 170,000 | $37.30 | $6.3M | Form 4 |
| Feb 23, 2026 | Carey J. DormanPdt Enterprise Ops and CFO | Sold | 97,500 | $34.87 | $3.4M | Form 4 |
| Feb 20, 2026 | Oneal E StanleyDirector | Sold | 200,641 | $35.52 | $7.1M | Form 4 |
| Dec 12, 2025 | Matthew LiebowitzPresident, Specialties | Sold | 37,000 | $26.60 | $1.0M | Form 4 |
| Nov 5, 2025 | Ian G H AshkenDirector | Sold | 292,000 | $27.00 | $7.9M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 8 / 9 | 7 / 9 |
| Accruals ratio | β4.4% | β2.4% | β2.0% |
| Altman Z'' | 1.49 | 2.01 | 2.53 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Element Solutions ESI | $8.1B | 3.8% | 13.4% | 8.9% | 6.5% | 39.1x | 7 | |
| NewMarket NEU | $8.0B | β2.2% | 20.0% | 18.0% | 16.3% | 18.7x | 5 | Compare β |
| Stepan SCL | $1.5B | 7.0% | 3.4% | 1.1% | 3.6% | β | 6 | Compare β |
| Minerals Technologies MTX | $2.0B | β2.2% | 2.3% | 4.2% | 1.6% | β | 4 | Compare β |
| Avient AVNT | $3.8B | 0.6% | 6.2% | 6.0% | 4.0% | 22.2x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.8B | $1.9B | $2.0B | $1.8B | $1.9B | $2.4B | $2.5B | $2.3B | $2.5B | $2.6B |
| Gross profit | $777M | $814M | $838M | $788M | $786M | $961M | $953M | $919M | $1.0B | $1.1B |
| Research and development | $45.0M | $46.4M | $44.3M | $42.2M | $48.6M | $49.7M | $48.8M | $68.1M | $63.0M | $67.6M |
| Operating income | $89.4M | $200M | $249M | $249M | $233M | $300M | $325M | $174M | $344M | $342M |
| Interest expense | $360M | $323M | β | β | β | β | β | β | β | β |
| Pretax income | β$232M | β$260M | β$53.2M | $141M | $81.1M | $252M | $272M | $129M | $288M | $266M |
| Income tax | β$41.3M | β$68.6M | $23.8M | $61.3M | $4.3M | $48.3M | $85.8M | $13.0M | $44.8M | $74.6M |
| Net income | β$73.7M | β$296M | β$324M | $92.9M | $75.7M | $204M | $187M | $118M | $244M | $191M |
| Diluted EPS | β$0.65 | β$1.04 | β$1.13 | $0.35 | $0.30 | $0.82 | $0.76 | $0.49 | $1.01 | $0.79 |
| Diluted shares | 0.27B | 0.29B | 0.29B | 0.26B | 0.25B | 0.25B | 0.25B | 0.24B | 0.24B | 0.24B |
| Cash flow | ||||||||||
| Cash from operations | $185M | $182M | β$0.8M | $171M | $276M | $326M | $296M | $334M | $362M | $290M |
| Capital expenditure | $32.6M | $30.8M | $28.4M | $29.7M | $28.8M | $46.3M | $47.8M | $52.7M | $68.4M | $62.2M |
| Free cash flow | $152M | $151M | β$29.2M | $141M | $247M | $280M | $248M | $281M | $294M | $228M |
| Depreciation and amortization | $156M | $156M | $157M | $155M | $161M | $164M | $161M | $167M | $158M | $151M |
| Stock-based compensation | $7.3M | $11.8M | $15.4M | $11.8M | $6.0M | $40.1M | $17.7M | $9.4M | $14.8M | $59.1M |
| Acquisitions | $1.2M | $0.0M | $28.2M | $63.9M | $9.0M | $537M | $22.6M | $215M | $3.9M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $507M | $55.7M | $19.6M | $151M | $0.0M | $0.0M | $25.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $12.4M | $61.9M | $78.4M | $77.4M | $78.2M | $77.8M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $507M | $68.1M | $81.5M | $229M | $77.4M | $78.2M | $103M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $423M | $258M | $234M | $190M | $292M | $330M | $266M | $289M | $359M | $627M |
| Total debt | $5.2B | $5.5B | $5.4B | $1.5B | $1.5B | $1.9B | $1.9B | $2.0B | $1.8B | $1.6B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $2.1B | $2.3B | $2.5B | $833M | $990M | $1.2B | $1.2B | $1.2B | $1.3B | $1.6B |
| Current liabilities | $1.1B | $1.1B | $1.1B | $294M | $314M | $415M | $344M | $369M | $380M | $430M |
| Inventory | $416M | $186M | $188M | $200M | $203M | $274M | $291M | $299M | $246M | $295M |
| Property and equipment, net | $461M | $287M | $267M | $265M | $240M | $278M | $277M | $297M | $277M | $320M |
| Total assets | $10.1B | $10.3B | $9.4B | $4.3B | $4.5B | $5.1B | $4.9B | $5.0B | $4.9B | $5.1B |
| Total liabilities | $7.2B | $7.4B | $7.2B | $2.1B | $2.2B | $2.6B | $2.6B | $2.6B | $2.5B | $2.4B |
| Shareholders' equity | $2.7B | $2.7B | $2.1B | $2.2B | $2.3B | $2.5B | $2.3B | $2.3B | $2.4B | $2.7B |
| Margins | ||||||||||
| Gross margin | 43.9% | 43.3% | 42.7% | 42.9% | 42.4% | 40.0% | 37.4% | 39.4% | 42.2% | 42.0% |
| Operating margin | 5.1% | 10.7% | 12.7% | 13.6% | 12.6% | 12.5% | 12.8% | 7.4% | 14.0% | 13.4% |
| EBITDA margin | 13.9% | 19.0% | 20.7% | 22.0% | 21.3% | 19.3% | 19.1% | 14.6% | 20.4% | 19.3% |
| Net margin | β4.2% | β15.8% | β16.5% | 5.1% | 4.1% | 8.5% | 7.3% | 5.1% | 9.9% | 7.5% |
| FCF margin | 8.6% | 8.1% | β1.5% | 7.7% | 13.3% | 11.7% | 9.7% | 12.0% | 12.0% | 8.9% |
| Returns | ||||||||||
| Return on capital | 1.0% | 2.0% | 2.5% | 2.6% | 6.2% | 6.3% | 5.5% | 3.9% | 7.4% | 6.5% |
| Return on capital employed | 1.0% | 2.2% | 2.9% | 4.1% | 5.7% | 6.8% | 7.0% | 3.8% | 7.6% | 7.5% |
| Return on equity | β3.1% | β10.8% | β13.4% | 4.3% | 3.3% | 8.5% | 7.8% | 5.1% | 10.4% | 7.6% |
| Return on assets | β0.7% | β2.9% | β3.3% | 1.4% | 1.7% | 4.2% | 3.7% | 2.4% | 5.0% | 3.8% |
| Growth | ||||||||||
| Revenue growth | β30.4% | 6.1% | 4.4% | β6.4% | 1.0% | 29.5% | 6.2% | β8.5% | 5.3% | 3.8% |
| Net income growth | β | β | β | β | β18.5% | 169.1% | β8.1% | β36.9% | 106.8% | β21.9% |
| EPS growth | β | β | β | β | β14.3% | 173.3% | β7.3% | β35.5% | 106.1% | β21.8% |
| FCF growth | β44.3% | β0.6% | β119.3% | β | 75.1% | 13.2% | β11.3% | 13.2% | 4.5% | β22.5% |
| Share count change | 34.0% | 5.1% | 0.7% | β9.8% | β3.9% | β0.8% | β0.9% | β1.6% | 0.3% | β0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 19.6x | 14.7x | 12.8x | 3.4x | 3.2x | 3.5x | 3.4x | 4.9x | 3.0x | 2.1x |
| Debt / equity | 1.9x | 2.0x | 2.6x | 0.7x | 0.7x | 0.8x | 0.8x | 0.8x | 0.8x | 0.6x |
| Interest coverage | 0.3x | 0.6x | β | β | β | β | β | β | β | β |
| Current ratio | 1.9x | 2.1x | 2.2x | 2.8x | 3.2x | 2.9x | 3.5x | 3.2x | 3.3x | 3.7x |
| Quick ratio | 1.5x | 2.0x | 2.0x | 2.2x | 2.5x | 2.3x | 2.6x | 2.4x | 2.7x | 3.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.8% | 1.6% | 1.5% | 1.6% | 1.6% | 1.9% | 1.9% | 2.3% | 2.8% | 2.4% |
| Stock comp / revenue | 0.4% | 0.6% | 0.8% | 0.6% | 0.3% | 1.7% | 0.7% | 0.4% | 0.6% | 2.3% |
| Payouts / FCF | 0.0% | 0.0% | β | 359.1% | 27.6% | 29.1% | 92.5% | 27.6% | 26.6% | 45.2% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 4.0 | 3.0 | 9.0 | 7.0 | 6.0 | 6.0 | 5.0 | 8.0 | 7.0 |
| Altman Z'' | 0.9 | 1.1 | 1.0 | 1.2 | 1.4 | 1.6 | 1.7 | 1.5 | 2.0 | 2.5 |
| Accruals ratio | β2.6% | β4.7% | β3.3% | β1.1% | β4.6% | β2.5% | β2.2% | β4.4% | β2.4% | β2.0% |
Source: SEC EDGAR XBRL filings (CIK 0001590714). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.